Cbot a singleplex

Ended Purchase Order Awarded

Contract number
75D30123P17829
Awardee
Awarding agency
Obligated
$211,771

Award facts

Opportunity
  • 75D30123Q77261 Solicitation number
Contract value 100% obligated
$211,771.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30329, USA

Award details come from SAM.gov/FPDS.

About this award

XCR Diagnostics, Inc., a subsidiary of Fluoresentric, Inc., has been awarded a purchase order contract valued at two hundred eleven thousand seven hundred seventy-one dollars by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract is for the delivery of a singleplex CBOT A assay to CDC's facility in Atlanta, Georgia. The firm fixed price contract runs from September 12, 2023 through October 30, 2023. No set aside designation or subcontractors were indicated. The CDC works to protect public health and safety through the control and prevention of disease, injury, and disability, so this contract is likely supporting the agency's diagnostic testing capabilities.

Quick answers

Who was awarded contract 75D30123P17829?

75D30123P17829 was awarded to XCR Diagnostics, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 12, 2023.

How much is contract 75D30123P17829 worth?

The government has obligated $211,771 on 75D30123P17829.

Was contract 75D30123P17829 competed?

The extent of competition for 75D30123P17829 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award